Next Article in Journal
Sarcosine May Induce EGF Production or Inhibit the Decline in EGF Concentrations in Patients with Chronic Schizophrenia (Results of the PULSAR Study)
Next Article in Special Issue
Neurogenesis-Associated Protein, a Potential Prognostic Biomarker in Anti-PD-1 Based Kidney Renal Clear Cell Carcinoma Patient Therapeutics
Previous Article in Journal
A Critical Analysis of the FDA’s Omics-Driven Pharmacodynamic Biomarkers to Establish Biosimilarity
Previous Article in Special Issue
Prognosis and Personalized In Silico Prediction of Treatment Efficacy in Cardiovascular and Chronic Kidney Disease: A Proof-of-Concept Study
 
 
Article

Article Versions Notes

Pharmaceuticals 2023, 16(11), 1555; https://doi.org/10.3390/ph16111555
Action Date Notes Link
article xml file uploaded 2 November 2023 17:34 CET Original file -
article xml uploaded. 2 November 2023 17:34 CET Update -
article pdf uploaded. 2 November 2023 17:34 CET Version of Record https://www.mdpi.com/1424-8247/16/11/1555/pdf-vor
article supplementary file uploaded. 2 November 2023 17:34 CET - https://www.mdpi.com/1424-8247/16/11/1555#supplementary
article html file updated 2 November 2023 17:36 CET Original file -
article xml file uploaded 3 November 2023 10:20 CET Update -
article xml uploaded. 3 November 2023 10:20 CET Update https://www.mdpi.com/1424-8247/16/11/1555/xml
article pdf uploaded. 3 November 2023 10:20 CET Updated version of record https://www.mdpi.com/1424-8247/16/11/1555/pdf
article html file updated 3 November 2023 10:23 CET Update https://www.mdpi.com/1424-8247/16/11/1555/html
Back to TopTop